BioLine RX (Israel) Market Value
| BLRX Stock | ILS 8.00 0.20 2.56% |
| Symbol | BioLine |
BioLine RX 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLine RX's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLine RX.
| 08/29/2024 |
| 11/27/2024 |
If you would invest 0.00 in BioLine RX on August 29, 2024 and sell it all today you would earn a total of 0.00 from holding BioLine RX or generate 0.0% return on investment in BioLine RX over 90 days. BioLine RX is related to or competes with Evogene, Enlivex Therapeutics, Kamada, and Compugen. BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology More
BioLine RX Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLine RX's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLine RX upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 35.95 | |||
| Value At Risk | (11.73) | |||
| Potential Upside | 5.51 |
BioLine RX Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLine RX's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLine RX's standard deviation. In reality, there are many statistical measures that can use BioLine RX historical prices to predict the future BioLine RX's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.08) | |||
| Total Risk Alpha | (2.10) | |||
| Treynor Ratio | 1.77 |
BioLine RX Backtested Returns
BioLine RX secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23% return per unit of risk over the last 3 months. BioLine RX exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLine RX's Risk Adjusted Performance of (0.14), mean deviation of 3.66, and Standard Deviation of 5.97 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.65, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioLine RX are expected to decrease at a much lower rate. During the bear market, BioLine RX is likely to outperform the market. At this point, BioLine RX has a negative expected return of -1.39%. Please make sure to confirm BioLine RX's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if BioLine RX performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
BioLine RX has very good predictability. Overlapping area represents the amount of predictability between BioLine RX time series from 29th of August 2024 to 13th of October 2024 and 13th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLine RX price movement. The serial correlation of 0.84 indicates that around 84.0% of current BioLine RX price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 2.66 |
BioLine RX lagged returns against current returns
Autocorrelation, which is BioLine RX stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLine RX's stock expected returns. We can calculate the autocorrelation of BioLine RX returns to help us make a trade decision. For example, suppose you find that BioLine RX has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioLine RX regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLine RX stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLine RX stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLine RX stock over time.
Current vs Lagged Prices |
| Timeline |
BioLine RX Lagged Returns
When evaluating BioLine RX's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLine RX stock have on its future price. BioLine RX autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLine RX autocorrelation shows the relationship between BioLine RX stock current value and its past values and can show if there is a momentum factor associated with investing in BioLine RX.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLine Stock
BioLine RX financial ratios help investors to determine whether BioLine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLine with respect to the benefits of owning BioLine RX security.